Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: How many disgruntled shareholders will be urging a chance of management here

On the contrary, the shareprice today reflects a complete apathy towards the current transition story - the exitement Mr. Goerner was speaking of from the beginning (maybe you noted he stopped mentioning it since about more than eight, nine months) has not reached any new investors so far

If this were a Fortune 500 company then I could go along with your views.

The "Buffet" story was intended to show that there is "complete apathy" in ALL stocks and markets. To expect PTSC to buck the trend during the transition in the blink of an eye is, in my very humble opinion, a request too far.

Would I like to see a higher share price? YES.

Am I concerned about the current price? NO.

After all is said and done, this is still an OTCBB stock, and I wish it would be treated as such.

Be well

Share
New Message
Please login to post a reply